Menu
Back to Journals » International Medical Case Reports Journal » Volume 15
Case report
Case Reports
The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,075 | Dovepress* | 4,768+ | 243 | 5,011 | |
| PubMed Central* | 307 | 50 | 357 | ||
| Totals | 5,075 | 293 | 5,368 | ||
| *Since 1 June 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 0 | 2 | 3 |
View citations on PubMed Central and Google Scholar